Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors

A pharmaceutical composition comprising:

• (a) a compound of the formula:
• or a pharmaceutically acceptable salt thereof;
• (b) at least one HMG CoA reductase inhibitor or a pharmaceutically acceptable salt thereof;
• and
• (c) one or more pharmaceutically acceptable excipients;
• wherein the composition comprises 1 mg to 25 mg of Compound A or a pharmaceutically acceptable salt thereof and 1 mg to 80 mg of the HMG CoA reductase inhibitor or a pharmaceutically acceptable salt thereof wherein the composition is formulated as an oral fixed dose combination for a once a day administration.